Concentrix Corp (NASDAQ:CNXC)
| Market Cap | $1.95B-7.2% |
| Revenue (ttm) | $9.97B+2.6% |
| Net Income | -$2.39B-856.3% |
| EPS | -$38.89-922.2% |
| Shares Out | 61.11M |
| PE Ratio | n/a |
| Forward PE | 2.78 |
| Dividend | $1.45(4.54%) |
| Ex-Dividend Date | Oct 23, 2026 |
| Volume | 709,342 |
| Open | $31.45 |
| Previous Close | $31.45 |
| Day's Range | $30.67 - $32.43 |
| 52-Week Range | $19.12 - $44.78 |
| Beta | 0.47 |
| Analysts | Buy |
| Price Target | $33.50(+4.82%) |
| Earnings Date | Jan 12, 2027 |
About CNXC
Concentrix Corporation operates globally, specializing in providing technology-enhanced solutions to optimize customer experiences (CX). The company's services encompass a wide array of offerings, including streamlining CX processes, driving technological innovation, automating both front-end and back-end operations, delivering insightful analytics, and facilitating comprehensive business transformations. Additionally, Concentrix assists clients with end-to-end customer lifecycle management, crafting effective customer/user experience strategies and designs, navigating digital shifts, and extracting valuable insights from "Voice of the Customer" data. Their diverse clientele spans various industries, such as consumer electronics, technology, e-commerce, and health insurance, as well as emerging global enterprises (IPOs), notable social media brands, and banking institutions. Concentrix Corporation was founded in 2009 and is headquartered in Fremont, California.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
Analyst consensus
1 firm rating CNXC in the last 3 months, one vote each. Issuer-paid research is not counted.
Next catalysts
- Jan 12, 2027Earnings report
$CNXC stock is featured in our Congress Trading, and Insider Trades datasets.
→ All Stock ListsCongress Trading
Recent trades of CNXC by members of U.S. Congress
| Michael T. McCaulHouse / R | Sale$15.00K – $50.00K | Sep 1, 2022 |
| Michael T. McCaulHouse / R | Sale$15.00K – $50.00K | Aug 23, 2022 |
| Michael T. McCaulHouse / R | Sale$1.00K – $15.00K | May 5, 2022 |
| Michael T. McCaulHouse / R | Purchase$1.00K – $15.00K | Feb 15, 2022 |
| Michael T. McCaulHouse / R | Sale$1.00K – $15.00K | Jan 28, 2022 |
| Michael T. McCaulHouse / R | Sale$1.00K – $15.00K | Dec 14, 2021 |
Recently reported changes in CNXC holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by CNXC's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
CNXC Estimated quarterly lobbying spending
Source: U.S. Senate LDA
CNXC Revenue by Segment or Geography
| Retail, travel and e-commerce | $662.61M | 27.00% |
| Technology and consumer electronics | $603.51M | 24.60% |
| Banking, financial services and insurance | $432.46M | 17.63% |
| Communications and media | $381.90M | 15.56% |
| Other | $228.01M | 9.29% |
| Healthcare | $145.17M | 5.92% |
As of: Q3 2026 (Aug 31, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New CNXC patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to CNXC from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in CNXC
| IJRiShares Core S&P Small-Cap ETF | $96.34M |
| IWMiShares Russell 2000 ETF | $42.51M |
| VTIVanguard Morningstar Total Stock Market ETF | $41.12M |
| VBVanguard Morningstar Small-Cap ETF | $29.14M |
| VBRVanguard Morningstar Small-Cap Value ETF | $18.96M |
| DFSVU.S. Small Cap Value Portfolio ETF Class Shares | $17.89M |
Estimated from each fund’s disclosed top holdings × AUM
Bull Case vs Bear Case
AI-generated from CNXC’s recent data — informational, not investment advice
What’s Behind the Score
News check: CFO succession and multiple AI/business expansion initiatives signal operational confidence; some valuation debate but no negative catalysts.